Lantern Pharma Inc. reports

Company location: Dallas, TX
Fiscal year end: 31 December

Lantern Pharma Inc. has filed 246 SEC EDGAR filings since 14 Jan 2019

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 151-175 of 246 matching filings.

Per page

Current page

4 filing

Filing date: 08 Nov 2021
Reporting date: 04 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4 filing

Filing date: 08 Nov 2021
Reporting date: 04 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4 filing

Filing date: 08 Nov 2021
Reporting date: 04 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4 filing

Filing date: 08 Nov 2021
Reporting date: 04 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4 filing

Filing date: 02 Nov 2021
Reporting date: 29 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4 filing

Filing date: 02 Nov 2021
Reporting date: 29 Oct 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-39318

QUARTERLY REPORT

Filing date: 01 Nov 2021
Reporting date: 30 Sep 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-39318

CURRENT REPORT

Filing date: 01 Nov 2021
Reporting date: 01 Nov 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39318

QUARTERLY REPORT

Filing date: 29 Jul 2021
Reporting date: 30 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-39318

CURRENT REPORT

Filing date: 29 Jul 2021
Reporting date: 29 Jul 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-257643

EFFECT filing

Filing date: 12 Jul 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 08 Jul 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 07 Jul 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-3 File 333-257643

REGISTRATION STATEMENT

Filing date: 02 Jul 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-39318

CURRENT REPORT

Filing date: 25 May 2021
Reporting date: 19 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-39318

CURRENT REPORT

Filing date: 03 May 2021
Reporting date: 03 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-39318

QUARTERLY REPORT

Filing date: 03 May 2021
Reporting date: 31 Mar 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

DEFA14A File 001-39318

DEFINITIVE ADDITIONAL MATERIALS

Filing date: 09 Apr 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-39318

DEFINITIVE PROXY STATEMENT

Filing date: 09 Apr 2021
Reporting date: 19 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-39318

ANNUAL REPORT

Filing date: 10 Mar 2021
Reporting date: 31 Dec 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-39318

CURRENT REPORT

Filing date: 10 Mar 2021
Reporting date: 10 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-91536

SC 13G

Filing date: 16 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-91536

SC 13G

Filing date: 16 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-91536

LANTERN PHARMA INC.

Filing date: 25 Jan 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 4 SUBMISSION

Filing date: 19 Jan 2021
Reporting date: 14 Jan 2021
SEC evidence: Open document Open filing
Next action: Verify source filing